Behavioral Health M&A Advisory: Buy-Side and Sell-Side Support, Translated Into Deal Economics
Buyers and sellers of behavioral health assets need advisors who can price regulatory risk, not just model EBITDA. Sariah Hopkins walks through what real M&A advisory covers, from EKRA exposure and 42 CFR Part 2 to CHOW licensure timing and escrow sizing.




